Recently, using a systemic TTP overexpression (TTPΔARE) mouse model, we demonstrated protective effects of enhanced TTP levels in chronic immune-mediated inflammatory diseases including mouse models of arthritis, psoriasis, and autoimmune encephalomyelitis (15). Here, ZFP36 is linked to arthritic joint disease.